lysergic acid diethylamide has been researched along with Premenstrual Syndrome in 2 studies
Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.
Premenstrual Syndrome: A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses.
| Excerpt | Relevance | Reference |
|---|---|---|
| "When treated with buserelin the difference disappeared." | 2.70 | Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment. ( Allard, P; Bäckström, T; Bixo, M; Mjörndal, T; Nyberg, S; Spigset, O; Sundström-Poromaa, I, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bixo, M | 1 |
| Allard, P | 2 |
| Bäckström, T | 2 |
| Mjörndal, T | 2 |
| Nyberg, S | 1 |
| Spigset, O | 2 |
| Sundström-Poromaa, I | 2 |
| Wihlbäck, AC | 1 |
2 trials available for lysergic acid diethylamide and Premenstrual Syndrome
| Article | Year |
|---|---|
Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment.
Topics: Adult; Blood Platelets; Buserelin; Cross-Over Studies; Double-Blind Method; Female; Follicular Phase | 2001 |
Influence of postmenopausal hormone replacement therapy on platelet serotonin uptake site and serotonin 2A receptor binding.
Topics: Blood Platelets; Carrier Proteins; Cross-Over Studies; Double-Blind Method; Estradiol; Estrogen Repl | 2001 |